Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells
Status:
Terminated
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
This study is for subjects with a type of skin cancer called melanoma. The main purpose of
this study is to examine the safety of the study drug (Poly-ICLC) in patients with your
disease. The study team would like to know about any side effects a patient may have when
given the study drug. Another goal of the study is to determine if combining dendritic cells
and the study drug can be possibly used as a vaccine for your disease.